promegestone has been researched along with Pituitary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, H; Murai, JT; Siiteri, PK; Sonnenschein, C; Soto, AM | 1 |
| Harrison, RW; Svec, F; Yeakley, J | 1 |
2 other study(ies) available for promegestone and Pituitary Neoplasms
| Article | Year |
|---|---|
Estrogen induction of progestophilins in rat estrogen-sensitive cells grown in media supplemented with sera from castrated rats and from rats bearing an alpha-fetoprotein-secreting hepatoma.
Topics: alpha-Fetoproteins; Animals; Cell Division; Cell Line; Culture Media; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Kinetics; Liver Neoplasms, Experimental; Pituitary Neoplasms; Promegestone; Rats; Receptors, Progesterone | 1984 |
Progesterone enhances glucocorticoid dissociation from the AtT-20 cell glucocorticoid receptor.
Topics: Animals; Binding, Competitive; Cell Line; Corticosterone; Cytosol; Kinetics; Mice; Pituitary Neoplasms; Progesterone; Promegestone; Receptors, Glucocorticoid; Receptors, Steroid; Triamcinolone Acetonide | 1980 |